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The transduction of biological signals often involves structural rearrangements of proteins in
response to input signals, which leads to functional outputs. This review discusses the role of regu-
lated partial and complete protein unfolding as a mechanism of controlling protein function and
the prevalence of this regulatory mechanism in signal transduction pathways. The principles of reg-
ulated unfolding, the stimuli that trigger unfolding, and the coupling of unfolding with other well
characterized regulatory mechanism are discussed.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction biological functions; consequently, these dynamic features are of-Proteins are the work horses of biological systems, performing a
plethora of tasks, including chemical catalysis, signal transmission,
molecular transportation, cellular movement and forming the
structural framework of cells and tissues. Protein function is dic-
tated by the primary amino acid sequence which, in turn, deter-
mines the three-dimensional organization and dynamic behavior
of proteins. Through evolution, proteins have achieved a ﬁne bal-
ance between thermodynamic stability and dynamic ﬂuctuations
to optimally perform their biological functions in the environmen-
tal setting of their host [1]. It has long been understood that the
three dimensional structure of a protein determines its function.
Growing evidence, however, establishes the pervasive roles of dis-
order and dynamics in mechanisms of protein function [2–6]. In
fact, nearly a third of all proteins, in all kingdoms of life, contain
disordered regions of at least 30 amino acids [7]. Disorder is man-
ifested in different ways, from short, ﬂexible linkers and long ‘‘ran-
dom coil-like’’ disordered segments to compact but disordered
domains and whole proteins termed intrinsically disordered pro-
teins (IDPs) [8]. Structural ﬂexibility and disorder mediates criticalten evolutionarily conserved [9,10]. A noteworthy example is the
topologically conserved activation loop in kinases [11]. In the inac-
tive state of Serine/Threonine and Tyrosine kinases (e.g., PKA, IRK)
the ﬂexible loop is collapsed on the active site, preventing sub-
strate binding. An evolutionarily conserved kinase activation
mechanism involves phosphorylation of this loop, which results
in (i) stabilization of an open conformation, and (ii) rearrangement
of key catalytic residues, enabling substrate binding and phospho-
transfer, respectively [11]. Classic allostery, which mediates signal
transduction through the tertiary and quaternary structure of pro-
teins (e.g., hemoglobin, receptor tyrosine kinases), causes struc-
tural rearrangements in one functional domain or subunit in
response to ligand binding within a distal domain/subunit of the
same protein [12]. This regulatory mechanism depends upon the
ability of whole proteins or domains to ﬂuctuate between different
deﬁned conformations to regulate function. However, accumulat-
ing evidence shows that partial or complete protein unfolding is
also utilized as a mechanism of regulating function, particularly
in signal transduction pathways. Here we introduce the concept
of regulated unfolding as a protein regulatory mechanism, provide
illustrative examples, and discuss its future implications.
2. Protein unfolding as a type of signaling output
Signaling mechanisms often involve posttranslational modiﬁca-
tions and/or protein–ligand (e.g., protein, nucleic acids, lipid, etc.)
interactions that couple an upstream input to a conformational
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The extent of the conformational change ranges from subtle, local
unfolding events to full unfolding of protein domains. For example,
the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 (p27) regulates
progression through the cell division cycle by interacting with and
inhibiting several Cdk/cyclin complexes in the nucleus [13]. Cell
cycle progression to S phase is characterized by rapid turnover of
p27 via the proteasome pathway, a fate which is signaled by phos-
phorylation of p27 on Thr187 [14]. Counter intuitively, this post-
translational modiﬁcation is performed by the Cdk/cyclin
complexes for which p27 is a potent inhibitor [14,15]. Grimmler
et al. [14], demonstrated that non-receptor tyrosine kinases phos-
phorylate Tyr88 of p27, a residue which occupies the active site of
Cdk2 [16]. This modiﬁcation causes an inhibitory 310 helix contain-
ing Tyr88 to be ejected from the ATP binding pocket of Cdk2, par-
tially restoring kinase activity. Intrinsic ﬂexibility of the C-terminal
domain of p27 allows Thr187 to ﬂuctuate into close proximity to
the Cdk active site and become phosphorylated, creating a phos-
phodegron that leads to selective p27 ubiquitination and degrada-
tion, and ultimately full activation of Cdk/cyclin complexes (Fig. 1).
Regulated partial unfolding of the inhibitory conformation of p27
through tyrosine phosphorylation triggers this signaling cascade
that ultimately drives progression of cells into S phase of the divi-
sion cycle.
Regulated unfolding mechanisms are also involved in the con-
trol of programmed cell death. Cytoplasmic p53 tumor suppressor
initiates apoptosis by binding to and activating pro-apoptotic pro-
teins [17]. This lethal function is inhibited by association of p53
with the anti-apoptotic protein BCL-xL [18]. Release and activation
of p53 in response to DNA damage is signaled by a BH3-only pro-
tein ligand (PUMA) binding to BCL-xL. A p-stacking interaction be-
tween His113 in BCL-xL and Trp71 in PUMA, causes unfolding of
BCL-xL at an allosteric site comprising two a-helix structural ele-
ments and dissociation of p53 from BCL-xL [19]. This example
illustrates a signaling mechanism which combines traditional allo-
steric, ligand binding-induced structural changes with unfolding to
release a binding partner.
The Wiskott–Aldrich syndrome protein (WASP) provides an
example of both posttranslational modiﬁcation- and ligand bind-
ing-induced unfolding involving several protein domains. WASP
regulates cytoskeletal actin polymerization through direct interac-
tion of its C-terminal domain with the Arp2/3 and actin complex.
However, this domain is auto-inhibited through tertiary interac-
tions with other domains of WASP. Cdc42, a Rho-family GTPase,
signals activation of auto-inhibitedWASP to initiate actin polymer-
ization. Cdc42 and the C-terminal domain of WASP compete for
binding to the WASP GTPase binding domain (GBD). Activation ofCdk2/Cyclin A 
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Fig. 1. p27 as a signaling conduit. Tyrosine phosphorylation-dependent partial unfolding
degradation. Step 1 involves phosphorylation of Y88 of p27 that is bound to Cdk/cyclin co
ABL, Src, Lyn, and Jak2, which ejects Y88 from the ATP binding pocket of Cdk2 and restor
within the ﬂexible C-terminal domain of p27 by partially active Cdk2 through a pseudo u
a phosphodegron signal for ubiquitination of Lysine residues within the p27 C-terminus
selectively degraded by the 26S proteasome, leading to the release of fully active Cdk2/WASP by Cdc42 involves partial unfolding of the hydrophobic core
of the auto-inhibited conformation of WASP and folding of the
WASP-Cdc42 complex. Furthermore, the partially unfolded confor-
mation exposes Tyr291, a phosphorylation site for the non-recep-
tor tyrosine kinase Lyn. This modiﬁcation further relieves
inhibition and enables the unfolding required for the structural
switch to the Cdc42-bound conformation [20,21]. This activation
mechanism (Fig. 2A) is an example of regulated unfolding wherein
two input signals, posttranslational modiﬁcation and ligand bind-
ing, synergize to control the three-dimensional organization and
function of WASP with switch-like precision. Utilization of two in-
put mechanisms allows WASP to integrate disparate upstream sig-
nals [21] and to respond through regulated unfolding.
However, these two mechanisms are not the only inputs that
propagate biological signals through regulated unfolding. For
example, phototropins, a class of Ser/Thr kinases, play critical roles
in signal transduction in plants. Their activation is signaled by
exposure to blue light, when a covalent bond forms between a ﬂa-
vin chromophore and the light-oxygen-voltage 2 domain (LOV2),
causing unfolding of an inhibitory Ja helix and consequently the
activation of the kinase domain [22,23]. A similar mechanism is
utilized by a class of bacterial photoactivatable proteins [24]. These
examples have illustrated regulated unfolding mechanisms involv-
ing relatively subtle alterations of secondary and tertiary structure.
3. Protein shape-shifters
Other examples of regulated unfolding include a class of so-
called ‘metamorphic proteins’ ([25,26], Fig. 2B). The intriguing
structural shape-shifting of these proteins mediates multiple cellu-
lar functions. For example, the chemokine lymphotactin (Ltn)
switches between a monomeric a-helical and dimeric b-sheet
sandwich conformation. The monomeric form, which exhibits the
classical chemokine fold, binds to the canonical XCRI receptor. In
contrast, the dimeric form binds to heparin and localizes to the
plasma membrane [27]. The two mutually exclusive functional
states exist in equilibrium under physiological conditions and re-
quire global unfolding for their inter-conversion [28]. Mad2, a pro-
tein involved in regulation of the mitotic spindle assembly,
provides another example of metamorphic behavior. This protein
undergoes a signiﬁcant structural reorganization from an inactive
to active conformation which requires a partially unfolded inter-
mediate [29]. While the in vitro evidence for the alternative struc-
tures of metamorphic proteins supports the observations of
functional switching in cells, the exact mechanisms that regulate
conformational switching of Ltn and Mad2 in vivo are currently
not well understood.plex 
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Fig. 2. Examples of various regulated unfolding mechanisms involved in signaling. (A) Signal integration in the regulatory mechanism of WASP. In the autoinhibited form, the
GBD domain (blue and yellow boxes) is bound to the C-terminal VCA domain (red box), inhibiting the binding of VCA to the Arp2/3 complex (orange box). Binding of Cdc42
GTPase (coral object) to the GBD domain of WASP, which requires partial unfolding and remodeling of this binding site, releases VCA and activates WASP. Phosphorylation of
Y291 further stabilizes the active form of WASP. WASP integrates disparate signals (Cdc42 binding and phosphorylation by Lyn) to enable Arp2/3 binding and promote actin
polymerization. (B) Metamorphic proteins require partial or global unfolding to interconvert between different tertiary and quaternary structures. (C) Formation of colon
mucus through regulated unfolding of MUC2. (D) Functional cycle of the Hsp33 oxidative stress-response chaperone. The sensing domain (green) unfolds in response to
oxidative stress, leading to exposure of the substrate binding domain (red) that binds and holds partially unfolded substrates. Restoration of reducing conditions causes the
structure of the chaperone to revert to the folded, inactive form, releasing substrates to undergo folding under non-stress conditions.
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constitute the scaffold for formation of extensive biomolecular net-
works. Trimerization of MUC2 via its N-terminal domain, coupled
with dimerization via its C-terminal domain forms planar poly-
mers that assemble as stacked gel sheets on the inner epithelium
of the colon [30]. Compact, ring-shaped polymers composed of
folded monomers are stabilized in the presence of Ca2+ and at
low pH (6.2) and transported by secretory granulae to the epithe-
lial cell layer. At pH 7.4 and in the presence of chelating agents,
conditions which mimic those at the epithelial cell layer, the N-ter-
minal rings of MUC2 partially unfold, causing an expansion of the
proteinaceous network by greater than 1000-fold (Fig. 2C). This ex-
panded polymer is stabilized by covalent disulﬁde bonds formed
within the N-terminal trimerization domains [30]. The use of reg-
ulated unfolding maximizes the surface area that can be engaged
by the polymer and likely mediates the physical and mechanical
properties required for its function as a protective barrier in the co-
lon. The energy expenditure for delivering MUC2 from the site of
synthesis to the epithelial layer via the secretory pathway issigniﬁcantly reduced though the employment of the compact form
in early stages of the functional cycle.
4. Protein unfolding as a mechanism for revealing occluded
signals
While some proteins perform unique, well-deﬁned tasks, many
exhibit multiple functions, often performed in multiple subcellular
locations. A preponderance of these multi-functional proteins is in-
volved in cellular signaling. Translocation between subcellular
compartments is mediated by specialized machinery which recog-
nizes speciﬁc signals, such as nuclear localization (NLS) or nuclear
export signals (NES), which are encoded by short linear motifs
within the primary sequence [31]. The transport machinery is al-
ways active; therefore, switchable signals are needed to control
when a particular protein is transported from one cellular com-
partment to another. For example, KSRP, also known as FBP2, a
protein involved in various aspects of mRNA metabolism [32], con-
tains a 14-3-3f consensus binding sequence which is structurally
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of Ser193 causes the kinase domain of KH1 to unfold, consequently
revealing the 14-3-3f interaction site [33]. This regulated unfold-
ing event results in re-localization of KSRP to the nucleus in a
14-3-3f dependent manner [33] and reduction of the rate of mRNA
degradation [34]. A similar mechanism of exposing structurally
inaccessible localization signals is employed by the inﬂuenza virus
to hijack the nuclear import machinery of its host cell. The C-termi-
nal segment of viral polymerase PB2 unfolds in order to reveal a
bipartite NLS which binds to importin a5 and allows the parasitic
enzyme to enter the host cell nucleus and process newly synthe-
sized viral genomic material [35].
The Crk-like (CRKL) adaptor protein, involved in mediating a
variety of signal transduction cascades, including subcellular
re-localization and activation of kinases and other signaling mol-
ecules [36], is another example of a protein which harbors an
occluded recognition sequence [37]. An evolutionarily conserved
NES is encoded in SH3C, a functionally important domain of
CRKL that is otherwise uninvolved in recruitment of signaling
molecules. Through a combination of structural and biophysical
analyses, Harkiolaki et al. [37] demonstrated that the SH3C do-
main of CRKL is able to form a domain-swapped dimer that ex-
poses two symmetrically disposed NESs. These signals are
structurally occluded in the monomeric form of the protein
[37]. Interestingly, domain swapping is also employed by other
proteins as a method of regulating function [38,39]. The ‘hinge
loop’, a topologically required region for formation of domain
swapped dimers, switches from its collapsed conﬁguration in
the monomeric form to an extended conformation in the dimer.
This hinge loop is a favorable location for conditional signaling
sequences, such as sites of phosphorylation that regulate func-
tion, which become solvent exposed upon dimerization.
Tyr926, a conserved phosphorylation site in the ‘hinge loop’ of
the focal adhesion targeting (FAT) domain of focal adhesion ki-
nase (FAK) is modiﬁed by Src with greater efﬁciency when the
protein adopts the domain-swapped conformation, affecting
downstream signaling through the Ras-MAPK pathway [40,41].
Due to its critical role in maintaining DNA integrity and control-
ling cell fate, the level and activity of the tumor suppressor p53 is
controlled by complex signaling networks involving a staggering
number of positive and negative feedback systems [42]. Acetyla-
tion of tetrameric p53 by the acetyltransferase p300 enhances spe-
ciﬁc DNA binding [43]. The acetylation site, located in the C-
terminal regulatory domain of p53, is sterically occluded when this
domain is phosphorylated, but becomes accessible for p300 modi-
ﬁcation when p53 binds to DNA, as well as under heat-denatur-
ation conditions. These results suggest an allosterically regulated
local unfolding mechanism [44].
Central to the conserved, inter-cellular Notch signaling pathway
are the Notch family ofmodular, single-pass transmembrane recep-
tors [45]. In their resting state, Notch receptors adopt an auto-
inhibited fold, in which two key proteolytic sites, S2 and S3, located
within the negative regulatory region (NRR) are sterically protected
from proteolytic cleavage. Binding of Notch on the signal-receiving
cell to a transmembrane ligand located on the signal-sending cell
causes ligand endocytosis as well as simultaneous endocytosis in
trans (into the signal-sending cell) of the ecto-domain of Notch
[45]. Since the transmembrane domain of Notch remains anchored
in the membrane of the signal-receiving cell, the adjacent NRR do-
main is subjected to mechanical strain, which exposes the occluded
S2 proteolytic site for cleavage [45]. In a molecular dynamics study,
Chen and Zolkiewska [46] identify the protease-sensitive confor-
mation of Notch1 as an on-pathway unfolding intermediate, in
which two Lin12/Notch repeats dissociate from the heterodimer-
ization domain (HD), causing unfolding of a secondary structure
element within HD that contains S2. Furthermore, Stephensonand Avis [47] demonstrated through a combination of atomic force
microscopy, biophysical assays and molecular dynamics that a b-
strand containing the S2 site within the NRR domain of Notch2
undergoes stepwise unfolding in response to pulling force. Unfold-
ing of the S2 site exhibited a low energy barrier and was an early
event on the unfolding pathway. Experimental evidence associated
the unfolding of the S2-containing structural element with proteo-
lytic cleavage by the TACE and ADAM10 proteases, linking mechan-
ically-induced unfolding with trans-endocytosis, a critical step in
the Notch signaling pathway.
The mechanism of regulated unfolding as a means of exposing
hidden signaling sequences is also utilized by a giant amongst pro-
teins, the Van Willebrand factor (VWF), which forms ultra-large
multimers. Buried protease recognition sites are revealed via local
unfolding generated by tensile force created in response to arterial
bleeding. Cleavage by the metalloprotease ADAMTS13 severs the
ultra-large VWF multimers into smaller oligomers as part of a reg-
ulatory mechanism of hemostasis [48,49].
Together, these ﬁndings demonstrate that regulated unfolding
to expose otherwise structurally occluded signaling sequences is
a frequently utilized and effective mechanism for controlling the
functional repertoire of numerous multi-tasking proteins.5. Protein unfolding as a mechanism for modulating ligand
binding afﬁnity
Modulation of protein ligand binding afﬁnity is another preva-
lent regulatory mechanism utilized in transcriptional regulation
[50], signal transduction [51–53], metabolism [54] and other bio-
logical processes. The mechanisms employed include allosteric
regulation [52–54], assembly of multi-subunit complexes [50],
and modulation of binding site afﬁnity via homo- or hetero-oligo-
merization [50]. Regulated unfolding is also utilized as a means to
decrease binding afﬁnity [19,55], and somewhat counter intui-
tively, to enhance substrate binding afﬁnity [56].
Chaperones are molecular machines that recognize misfolded
proteins and promote their refolding. Interestingly, cellular stress
signals that trigger protein misfolding also initiate chaperone acti-
vation. For example, stress-responsive chaperones, such as the bac-
terial holdases Hsp33 [49,57,58] and HdeA [59,60], are activated
upon oxidative stress and a drop in cellular pH, respectively. Strik-
ingly, activation of these chaperones is achieved through condi-
tional domain unfolding [56]. The structural transition to the
partially unfolded state confers high afﬁnity towards partially un-
folded chaperone substrates, to which they bind and ‘hold’ until
environmental conditions favor native protein folding. When these
normal conditions are restored, substrates are released and al-
lowed to fold independently [60] or are transferred to an ATP-
dependent foldase [49]. Exposure of hydrophobic surfaces on the
C-terminal substrate binding domain (the so-called ‘sensor’ do-
main) of the chaperone through regulated unfolding provides
selectivity and high binding afﬁnity for unfolding/misfolding inter-
mediates. Utilization of folded-to-unfolded transitions in the func-
tional cycle of these disordered chaperones provides twofold
functional advantages. First, this energy-independent mechanism
allows maintenance of proteostasis under stress conditions, when
the pool of ATP required by ATP-dependent chaperones is depleted.
Second, utilization of a disordered chaperone region for substrate
recognition enables binding to a broad pallete of unfolded protein
substrates [61].
The unfolding/folding functional cycle of Hsp33 has been ele-
gantly elucidated by Jakob and colleagues ([49] and Fig. 2D). Under
normal physiological conditions, the ‘sensor domain’ of Hsp33 is
stabilized by a Zn2+ ion which coordinates four highly conserved
cysteines. In response to oxidative stress, the stabilizing ion is
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tion of the four Zn-coordinating cysteines acts as an allosteric
switch that causes unfolding of the previously folded linker con-
necting the N- and C-terminal domains [62]. This unfolded linker
domain serves as the high-afﬁnity binding site for early unfolding
intermediates, while selecting against self-recognition for intrinsi-
cally disordered regions within the chaperone, as well as against
other cellular IDPs [49].
Unfolding is a means to dramatically decrease the binding afﬁn-
ity between two folded biomolecules. A particularly interesting
example of this regulatory mechanism involves the sarcoplasmic
reticulum (SR) Ca2+-ATPase (SERCA) and the SR integral membrane
protein phospholamban (PLN), which regulate cardiac contractility
[55]. Activation of SR and plasma-membrane Ca2+ channels in
myocytes causes increased cytoplasmic Ca2+ concentration and
leads to cellular contraction. SERCA, a SR calcium pump, mediates
transport of cytoplasmic Ca2+ into the SR lumen, causing muscle
relaxation [63]. PLN binding to SERCA inhibits SERCA-mediated
Ca2+ ﬂux from the cytoplasm into the SR. Phosphorylation of PLN
at Ser16 by PKA causes unfolding of domains Ia and Ib, positioned
in the cytoplasm and the hydrophilic layer of the SR membrane,
respectively. This modiﬁcation reduces the afﬁnity of PLN for SER-
CA and restores SERCA-mediated uptake of Ca2+ into the SR mem-
brane [55,63]. Through EPR and NMR-based analyses, Gustavsson
et al. [55], identiﬁed several partially disordered, alternative con-
formational states that exist in equilibrium with the folded form.
The equilibrium distribution of conformational states for the con-
ditionally unfolded species can be regulated by phosphorylation
and lipid binding, which determines the binding afﬁnity between
SERCA and PLN and regulates cardiac contraction. The Ia domain
of PLN is also involved in signal transduction by interacting with
a number of binding partners. This function is most likely enabled
by the conformational dynamics of this conditionally unstructured
domain [55].
6. Triggers of regulated unfolding
The cellular functions affected by regulated unfolding mecha-
nisms are highly diverse. Furthermore, the extent of disorder in-
duced during signal switching ranges from subtle, local unfolding
events [35,37,44,48,64] to unfolding of entire domains
[30,55,65,66]. Similarly diverse is the spectrum of molecular trig-
gers that unleash regulated unfolding events.
6.1. Environmental stimuli
Changes in chemical environment, such as alteration of pH
[30,60], redox conditions [49], exposure to light [22–24,67], and
metal ion concentrations [30,55], are signals that trigger cells to
activate speciﬁc regulatory pathways (Fig. 3). These stimuli can af-
fect the physico-chemical properties of proteins, providing a mech-
anism for coupling them with structural changes (e.g., unfolding)
and downstream signaling. For example, oxidative-stress condi-
tions promote disulﬁde bond formation between Cys residues in
Hsp33 and signal activation of the chaperone through conditionalPosttranslational modification,
mechanical force,
ligand binding,
oxidation/reduction,
pH change
Triggering stimuli
Fig. 3. Several different triggering stimuli mediaunfolding [66] and chelation of stabilizing Ca2+ ions promotes
unfolding and physical expansion of the colon mucus [30].
6.2. Chemical modiﬁcation
The state of foldedness of proteins is also controlled by chemical
modiﬁcations arising from posttranslational modiﬁcations
[14,55,64,65,68]. An illustrative example is the cyclic phosphoryla-
tion and dephosphorylation of the SERCA/PLN system [55] that
modulates the regulated unfolding mechanism responsible for
controlling cardiac contractility. Another example is regulation of
the Cdk inhibitory activity of p27 by tyrosine phosphorylation,
which disrupts the inhibitory conformation and partially activates
Cdk activity [14]. A plethora of other posttranslational modiﬁca-
tions, including acetylation [44], methylation, ubiquitination,
sumoylation, etc., are either known to, or likely to mediate regu-
lated unfolding events within diverse signaling pathways.
6.3. Ligand binding
Protein–protein interactions constitute the basis for intracellu-
lar signaling. Often, these interactions are triggered by structural
rearrangements of one or more of the binding partners, either at
the interaction site or at an allosterically regulated site. Several
protein re-activation mechanisms employ ligand binding-induced
unfolding steps. For instance, the C-terminal domain of inactivated
peroxiredoxin must unfold when bound to the repair enzyme sul-
phiredoxin, in order to allow access to its active site [69]. PUMA
binding to BCL-xL induces local unfolding of an allosteric site,
thereby signaling release and activation of the tumor suppressor
p53 [19]. Local unfolding induced by ligand binding has been ob-
served in mechanisms that regulate the sub-cellular localization
of proteins. For example, the C-terminal segment of the inﬂuenza
virus polymerase unfolds when bound to human importin a5 for
efﬁcient nuclear import [35] and the nuclear export signal of CRKL
becomes accessible only upon local unfolding of the polypeptide
chain, upon self-association into a domain-swapped dimer [37].
Proteins are dynamic entities that sample multiple conformations
within their folding landscape [70]. For the protein examples dis-
cussed here, intrinsic ﬂuctuations within this landscape are en-
hanced through regulated unfolding to enable exposure of
otherwise occluded binding sites, providing a mechanism for en-
abling interactions in a tightly controlled manner.
6.4. Mechanical force
In addition to chemical modiﬁcations and ligand binding,
mechanical force is an important regulatory mechanism employed,
in particular, in the muscular and vascular systems. Mechanical
stress-induced local unfolding of titin in striated muscle is thought
to play an important role in regulating its kinase activity [71],
while ﬂuid shear stress in blood vessels controls the length and
function of the thrombogenic factor VWF, by exposing a buried
proteolytic site [48]. Furthermore, trans-endocytosis of the ecto-
domain of Notch receptor exerts mechanical strain within itsAltered sub-cellular 
localization, altered ligand 
binding affinity, altered 
function (e.g., activation or 
inactivation)
Output signals
te protein unfolding and regulate function.
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exposes otherwise occluded sites for proteolytic cleavage, allowing
propagation of Notch signals [46,47].
The existence of these diverse triggering mechanisms highlights
the broad utilization of regulated unfolding in all kingdoms of life
and as a response to widely divergent environmental stimuli.
7. Concluding remarks
The process of protein unfolding is utilized by all organisms to
facilitate amino acid recycling [72] and to transport macromole-
cules through membranes, by threading them through tight pores
[73]. Here we show that all kingdoms of life utilize mechanisms
involving regulated protein unfolding to mediate signal transduc-
tion. Evolutionary conservation of the protein regions involved in
regulated unfolding (e.g., the conserved occluded NES in CRKL
[37], tyrosine residues within Cdk inhibitors [74], etc.) highlights
the biological importance of this type of signaling mechanism. A
theme that emerges from the examples discussed above is that,
through various triggering mechanisms, regulated unfolding is a
means to alter the dynamic properties of proteins, or segments
within them, and, in so doing, alter protein function. Enhanced
sampling of unfolded, or less structured, states in response to the
triggering stimuli discussed above provides physical mechanisms
for proteins to transmit biological signals [26].
Partial or global unfolding of proteins or protein domains facil-
itates interconversion between isoenergetic, alternative conforma-
tional states. Often, the structural rearrangement exposes new
hydrophobic interaction surfaces and thus promotes the formation
of oligomers [26]. For example, the metamorphic proteins Mad2
and Ltn [26] have evolved alternative folds [75], with one of two
folds stabilized via dimerization and at least partial unfolding re-
quired for the structural transition between these conformational
states [26,28,29]. Furthemore, the form of CRKL that is exported
from the nucleus is a domain swapped dimer with an unfolded
segment that contains a NES [37]. Oligomerization is a mechanism
for enhancing the functional complexity associated with a particu-
lar protein sequence [26,75] and this complexity can be further en-
hanced via regulated unfolding to control transitions between
different oligomeric states [26–29,37,55,68].
Recent advances in NMR spectroscopy methodology [76] and
single molecule techniques (e.g., atomic force microscopy [77], sin-
gle molecule ﬂuorescence [78,79]) have allowed detailed charac-
terization of the molecular mechanisms by which structural
ﬂuctuations mediate protein function. For example, NMR relaxa-
tion studies have shown that enzymes ﬂuctuate between different
sets of structural states at different stages of catalytic cycles [80].
Furthermore, Kay and co-workers have characterized lowly popu-
lated unfolding intermediates for several proteins using similar
NMR methods [81,82]. In addition, single-molecule FRET tech-
niques identiﬁed alterations in the folding pathway of a-synuclein
due to mutations associated with Parkinson’s disease [83]. Ad-
vances in computational methods in studies of protein folding
and unfolding, as well as advances in computing power, provide
opportunities to understand regulated unfolding mechanisms in
atomistic detail. An illustrative example is the mechanism that
controls VWF size in arterial thrombosis (reviewed in [84]) which
was elucidated though a combination of molecular dynamics
[85,86], single molecule experiments [48,87], X-ray crystallogra-
phy [88] and biophysical assays [86,89]. Together, these ap-
proaches will be valuable tools in future studies into the roles of
regulated unfolding—from subtle order-to-disorder transitions to
large-scale polypeptide unfolding—in protein function. Impor-
tantly, the identiﬁcation of functionally relevant unfolded states
requires monitoring dynamics on multiple time-scales whichnecessitates the use of complementary experimental and compu-
tational techniques.
We anticipate that the list of proteins recognized to utilize reg-
ulated unfolding will grow, as conformational states identiﬁed in
biophysical assays as simple folding/unfolding intermediates are
shown to be physiologically relevant. Similar to the example of lo-
cal unfolding and acetylation of p53 in response to DNA binding
[44], these intermediates may be stabilized through the types of
triggering modiﬁcations discussed above. For example, we pro-
posed that the multifunctional protein nucleophosmin (NPM1), a
histone chaperone involved in ribosome biogenesis, cell cycle con-
trol and tumor suppression [90], may use regulated unfolding of its
N-terminal domain from a folded b-sheet rich pentamer to a disor-
dered monomer in order to switch functions and sub-cellular local-
ization [68]. Identiﬁcation and characterization of functionally
relevant unfolded states for other proteins will require addressing
several challenges, such as (i) identiﬁcation of switching triggers
through biochemical, structural and cellular investigations, (ii) elu-
cidation of the functional outcome(s) of the regulated unfolding
phenomena, (iii) determination of the lifetimes of the unfolded
species in an appropriate functional setting, and (iv) elucidation
of the mechanisms by which regulated unfolding signals are reset
when triggering stimuli are absent.
Finally, our growing knowledge of the broad utilization of reg-
ulated unfolding mediated by diverse triggering mechanisms pro-
vides opportunities for applications in protein engineering. In fact,
mechanisms that couple protein domain folding and unfolding
have been previously explored as general designs for biomolecular
switches, with mechanical force [91–93], Ca2+ ion binding [94,95]
and proteolytic cleavage [96] utilized as input signals, and alter-
ation of protein function as the output signal. Understanding the
structural and biophysical underpinnings of regulated unfolding
mechanisms will advance our knowledge of multifunctional pro-
tein regulation. It is likely that understanding the physical princi-
ples of evolutionarily selected mechanisms of regulated
unfolding will lead protein design efforts in new directions, with
possible applications in the biotechnology and pharmaceutical
industries.
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